Robert A. Michael - 28 Feb 2023 Form 4 Insider Report for AbbVie Inc. (ABBV)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
02 Mar 2023, 15:30:28 UTC
Prior SEC filing
21 Feb 2023
Next SEC filing
20 Feb 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Steven L. Scrogham, attorney-in-fact for Robert A. Michael

Key filing fact

Robert A. Michael filed Form 4 for AbbVie Inc. (ABBV) on 02 Mar 2023.

Key facts

  • This page summarizes Robert A. Michael's Form 4 filing for AbbVie Inc. (ABBV).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Mar 2023, 15:30.

Change

  • Previous filing in this sequence was filed on 21 Feb 2023.
  • Current net transaction value: -$7,457,124.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ABBV transaction

Common Stock, $0.01 par value

Tax liability

Transaction value
$7,457,124
Shares
-48,335
Change %
-33%
Price
$154.28
Shares after
98,645
Date
28 Feb 2023
Ownership
Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .